Member Info for surprised

lol...open market buying been closed off....demand outstripping share supply at this minute :-)

mm's seeking sells.....wont let any open buying ..Friday just got a lot more interesting and more new products :-)

NT to buy again :-)

consolidation period (to become, or cause something to become, stronger, and more certain) looks like it may be over :-)

just gone NT to buy any amount..will take any sell :-)

Cenkos will likely be a more positive and active broker than Allenby has been , change Rob ( not at all) Speed in the pr dept too and we enter a new era as CPX develop from minnow to a global player ...

with respect Mr open, you've ignored all the 'help' everyone, including me has offered....at 3p, 6p, 9p and 14p....you ignored everyone's advice to buy or slice profits (it appears from your comments)....your last ten posts provide all the evidence of your mischievous postings, that's fine it's all part of stock market 'games' etc...but please do not expect me or others to believe you are seeking 'advice or help', that is hugely disingenuous..anyway enough of that as it's a distraction to the bb and focus on CPX potential outlook.

Here's some 'help' or an insight imo, IP protection as we all know is hugely important, court awarded Iouxus to pay CPX damages and they are in pursuit, a deterrent to others and a precedent has also been set. Any money eventually received will be a welcome bonus to the main business of manufacturing CPX extensive range of products both new and old.

Re share price, after a steep rise such as we have seen in recent months, a share needs a period of consolidation, typically it pulls back from recent highs (14p) and then trades for a time in a lower range consolidating (to become, or cause something to become, stronger, and more certain) before the next move up if the news supports such (all indicators are business is on track, manufacturing, order book double and increasing etc)...hope that helps ;-)

https://twitter.com/surprised_trade/status/1385484818708901888

trading in the 70p-80p consolidation range before next leg up. Afterpay share price (A$123) has an intrinsic link to #TSL & looks set to continue growing....

https://twitter.com/bidderadam/status/1385485891645460480

The link between APT & #TSL has widened again this month. In April APT is up 20% but #TSL slightly down. My NAV for #TSL is now 114.4p so over 50% upside. And thats before any APT rise which I think could happen on this weeks update

https://www.news.com.au/finance/business/retail/afterpay-confirms-it-is-considering-listing-on-the-us-stock-market/news-story/202630ddbabaa864041b980a5a6cc208

well there is no need for abusive messages Mr Open, I have no idea where 'superior' aspect comes from, however, you are an experienced investor, been in CPX for many years, consistently provide alternative arguments against your own and others investment in CPX , which in the right context may well be helpful to us all, however, I think history suggests 'mischevious' postings often describes your comments.
It takes all sorts to make a market, both positive and negative, I get that, however , I'm sure we can all be civil ....

it'll help pass the time between the next trading updates or news breaks on some other aspect...Manufacturing should be gradually ramping up in CPX own factory, be interesting if enquiries for new business are still increasing along with news of any new products and uses. The supercacitor outlook iscertainly one of growth and opportunity and the move to energy harvesting, green cre dentials, battery use , IOT etc etc. ..yup a whole lot of topics for debate :-)

a good debate is always fun ;-)

both lazy and mischievous are allowed if others wish to play along , by the way :-)

Morning Mr Open, all that info you 'request' has been discussed many times on the bb and all in the previous posts over past few months and in the public domain....I think you're being lazy or mischievous ;-)

lol, mkts can and do go either way at times, down a little (it can only drop a few pence as we are only 8p) or a long way up (there's no limit that way, and we've touched 14p recently, even higher before )...so at times both views will be right for a period of time....it's what makes a market...I remember at under 3p a few negative views, however, the lows then were clearly a positive moment to secure some shares, isn't that often the case,.......CPX has moved on from there, order book now double and production underway in their own new factory etc.... :-)

did someone buy 50 grand yesterday in little 'ol CPX I see from the trades list, could be good timing :-)

Jack Blumenfeld filed the 'motion' he appears still involved, the reps withdrawn are named in the linls posted earlier, for some reason they have withrawn this group of counsel, impossible to speculate an accurate reason as there are many possible casuses..interesting nonetheless....

re withdrawal , looks like a big shift and change as the original group were all included in the initial filings, MORRIS, NICHOLS that Jack Blumfield is a partner of are still involved, Jack Blumfield was also involved in the Iouxus patent infingement (https://portal.unifiedpatents.com/litigation/Delaware%20District%20Court/case/1:18-cv-00849 )
and as can be seen in the link below the reps withdrawn are named below when case started.
https://dockets.justia.com/docket/delaware/dedce/1:2019cv01733/70036

Interesting move, we await further news ....

''....Clients regularly turn to him in situations with a high risk of exposure that demand a thorough understanding of the complex legal and technical issues involved. Jack’s extensive experience includes pharmaceutical, medical product and biotechnology matters, as well as technology disputes involving computers, software and telecommunications. He has tried cases in various district courts and argued before the U.S. Court of Appeals for the Federal Circuit.

Jack has served as lead counsel for clients including Pfizer, UCB, Comcast, Thermo Fisher and Agilent, among many others, in patent and trade secret cases. His clients include major companies such as Amgen, Allergan, Gilead, Bayer, Becton Dickinson, AbbVie, Johnson & Johnson, Shire, Edwards Lifesciences, Google, Intel, Lenovo, Dell, Analog Devices, PayPal, Nokia, Activision, Electronic Arts, and Take Two.

Jack has received numerous awards and recognition, including having been named Delaware litigator of the year by Managing Intellectual Property. Chambers USA peer-review sources report that he is the “top Delaware IP lawyer” (2018) and “in a class of his own''

https://www.morrisnichols.com/lawyers-jack-b-blumenfeld

https://twitter.com/surprised_trade/status/1384498281418432522

https://www.news.com.au/finance/business/retail/afterpay-confirms-it-is-considering-listing-on-the-us-stock-market/news-story/202630ddbabaa864041b980a5a6cc208

https://twitter.com/surprised_trade/status/1384406268522242049

Revenue US$44.0 million, a 35.4% increase on Q1 2020 ..excellent figures, Broker Tamesis notes ''Capital reports record quarterly revenue with more to come as transformational contracts kick in...target sp 127p''